Cohance Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is CHLOROQUINE PHOSPHATE USP, with a corresponding US DMF Number 34130.
Remarkably, this DMF maintains an Active status since its submission on September 20, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 09, 2019, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II